Through the American Heart Association’s Rural Health Care Outcomes Accelerator, rural hospitals are leveraging peer learning to improve cardiovascular and stroke outcomes.

Results from three trials continue to demonstrate the potential of DATROWAY® (datopotamab deruxtecan) in combination with various immunotherapies to improve outcomes in patients with non-small cell ...